A detailed history of Ensign Peak Advisors, Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 35,823 shares of MEDP stock, worth $11.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
35,823
Previous 13,382 167.7%
Holding current value
$11.9 Million
Previous $5.41 Million 172.8%
% of portfolio
0.03%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$372.0 - $424.34 $8.35 Million - $9.52 Million
22,441 Added 167.7%
35,823 $14.8 Million
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $1.27 Million - $1.85 Million
4,467 Added 50.11%
13,382 $5.41 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $40,953 - $56,282
180 Added 2.06%
8,915 $2.73 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $62,004 - $74,642
265 Added 3.13%
8,735 $2.12 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $279,017 - $357,853
1,490 Added 21.35%
8,470 $2.03 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $26,146 - $35,928
150 Added 2.2%
6,980 $1.31 Million
Q4 2022

Feb 13, 2023

SELL
$153.06 - $226.57 $168,366 - $249,227
-1,100 Reduced 13.87%
6,830 $1.45 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $240,915 - $302,933
-1,660 Reduced 17.31%
7,930 $1.25 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $214,554 - $331,108
-1,545 Reduced 13.88%
9,590 $1.57 Million
Q4 2021

Feb 11, 2022

SELL
$182.74 - $227.9 $3.26 Million - $4.07 Million
-17,865 Reduced 61.6%
11,135 $2.42 Million
Q2 2021

Aug 13, 2021

BUY
$158.62 - $194.3 $967,582 - $1.19 Million
6,100 Added 26.64%
29,000 $5.12 Million
Q4 2020

Feb 12, 2021

SELL
$109.38 - $149.19 $65,628 - $89,514
-600 Reduced 2.55%
22,900 $3.19 Million
Q4 2019

Feb 14, 2020

BUY
$70.08 - $84.64 $1.65 Million - $1.99 Million
23,500 New
23,500 $1.98 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.